Industry Research Reports
Global Heparin Market Research Report 2025
Industry: Pharma & Healthcare
Published Date: 2025-08-27
Pages: 91 Pages
Report ld: 3469546
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Heparin Market Size(US$)
CAGR 2025-2031
7.8%
Market Size,2031
USD 2,301
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 1,469 million
Market Forecast in 2031(Value)
US$ 2,301 million
CAGR
7.8%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Heparin was valued at US$ 1225 million in the year 2024 and is projected to reach a revised size of US$ 2301 million by 2031, growing at a CAGR of 7.8% during the forecast period.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Heparin competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
In 2024, global Heparin production reached approximately 23,498 billion units , with an average global market price of around US$ 52,147 per billion units. Heparin is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium. In this report, we mainly study the Heparin API.
Global key players of Heparin include Shenzhen Hepalink Pharmaceutical, Yantai Dongcheng Pharmaceutical, Nanjing King-friend Biochemical Pharmaceutical, Pfizer, Hebei Changshan Biochemical Pharmaceutical, etc. The top five manufacturers hold a share about 54%. China is dominating the global Heparin market, has a share over 65% in terms of production. Europe and Asia-Pacific are the two largest market, both having a share about 34%, followed by North America, with a share about 30 percent.
The heparin API market is primarily driven by the rising global prevalence of cardiovascular and thromboembolic diseases, along with increasing surgical procedures. Growing aging populations and higher obesity rates contribute to sustained demand for anticoagulants. Additionally, heparin's use in treating COVID-19-associated thrombotic complications has further propelled market expansion. Pharmaceutical industry advancements in emerging markets (e.g., China and India) and the biopharmaceutical sector's demand for high-quality heparin also fuel market growth.
Key trends in the heparin API market include: 1) a technological shift from animal-sourced heparin (porcine intestinal mucosa extraction) to synthetic alternatives (e.g., low-molecular-weight heparin); 2) stringent regulatory requirements for supply chain traceability and quality control; 3) intensified competition from biosimilars, driving process optimization and cost reduction; and 4) the rise of local pharmaceutical players in emerging markets, diversifying the global heparin supply chain.
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Heparin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Heparin.
The Heparin market size, estimations, and forecasts are provided in terms of sales volume (billion units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Heparin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Heparin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Shenzhen Hepalink Pharmaceutical
Yantai Dongcheng Pharmaceutical
Pfizer
Bioibérica
Changzhou Qianhong Biopharma
Nanjing King-friend Biochemical Pharmaceutical
Hebei Changshan Biochemical Pharmaceutical
Qingdao Jiulong Biopharmaceutical
Opocrin
Dongying Tiandong Pharmaceutical
Aspen Oss
Yino Pharma
Nanjing Xinbai Pharmaceutical
Hubei Enoray Biopharmaceutical
Cisen Pharmaceutical
Segment by Type
Heparin Sodium
Heparin Calcium
Segment by Application
UFH
LMWH
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Heparin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Heparin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Heparin Market Overview
1.1 Product Definition
1.2 Heparin by Type
1.2.1 Global Heparin Market Value Comparison by Type (2024 VS 2031)
1.2.2 Heparin Sodium
1.2.3 Heparin Calcium
1.3 Heparin by Application
1.3.1 Global Heparin Market Value by Application (2024 VS 2031)
1.3.2 UFH
1.3.3 LMWH
1.4 Global Heparin Market Size Estimates and Forecasts
1.4.1 Global Heparin Revenue 2020-2031
1.4.2 Global Heparin Sales 2020-2031
1.4.3 Global Heparin Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Heparin Market Competition by Manufacturers
2.1 Global Heparin Sales Market Share by Manufacturers (2020-2025)
2.2 Global Heparin Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Heparin Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Heparin, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Heparin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Heparin, Product Type & Application
2.7 Global Key Manufacturers of Heparin, Date of Enter into This Industry
2.8 Global Heparin Market Competitive Situation and Trends
2.8.1 Global Heparin Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Heparin Players Market Share by Revenue
2.8.3 Global Heparin Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Heparin Market Scenario by Region
3.1 Global Heparin Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Heparin Sales by Region: 2020-2031
3.2.1 Global Heparin Sales by Region: 2020-2025
3.2.2 Global Heparin Sales by Region: 2026-2031
3.3 Global Heparin Revenue by Region: 2020-2031
3.3.1 Global Heparin Revenue by Region: 2020-2025
3.3.2 Global Heparin Revenue by Region: 2026-2031
3.4 North America Heparin Market Facts & Figures by Country
3.4.1 North America Heparin Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Heparin Sales by Country (2020-2031)
3.4.3 North America Heparin Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Heparin Market Facts & Figures by Country
3.5.1 Europe Heparin Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Heparin Sales by Country (2020-2031)
3.5.3 Europe Heparin Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Heparin Market Facts & Figures by Region
3.6.1 Asia Pacific Heparin Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Heparin Sales by Region (2020-2031)
3.6.3 Asia Pacific Heparin Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Heparin Market Facts & Figures by Country
3.7.1 Latin America Heparin Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Heparin Sales by Country (2020-2031)
3.7.3 Latin America Heparin Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Heparin Market Facts & Figures by Country
3.8.1 Middle East and Africa Heparin Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Heparin Sales by Country (2020-2031)
3.8.3 Middle East and Africa Heparin Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Heparin Sales by Type (2020-2031)
4.1.1 Global Heparin Sales by Type (2020-2025)
4.1.2 Global Heparin Sales by Type (2026-2031)
4.1.3 Global Heparin Sales Market Share by Type (2020-2031)
4.2 Global Heparin Revenue by Type (2020-2031)
4.2.1 Global Heparin Revenue by Type (2020-2025)
4.2.2 Global Heparin Revenue by Type (2026-2031)
4.2.3 Global Heparin Revenue Market Share by Type (2020-2031)
4.3 Global Heparin Price by Type (2020-2031)
5 Segment by Application
5.1 Global Heparin Sales by Application (2020-2031)
5.1.1 Global Heparin Sales by Application (2020-2025)
5.1.2 Global Heparin Sales by Application (2026-2031)
5.1.3 Global Heparin Sales Market Share by Application (2020-2031)
5.2 Global Heparin Revenue by Application (2020-2031)
5.2.1 Global Heparin Revenue by Application (2020-2025)
5.2.2 Global Heparin Revenue by Application (2026-2031)
5.2.3 Global Heparin Revenue Market Share by Application (2020-2031)
5.3 Global Heparin Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Shenzhen Hepalink Pharmaceutical
6.1.1 Shenzhen Hepalink Pharmaceutical Company Information
6.1.2 Shenzhen Hepalink Pharmaceutical Description and Business Overview
6.1.3 Shenzhen Hepalink Pharmaceutical Heparin Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Shenzhen Hepalink Pharmaceutical Heparin Product Portfolio
6.1.5 Shenzhen Hepalink Pharmaceutical Recent Developments/Updates
6.2 Yantai Dongcheng Pharmaceutical
6.2.1 Yantai Dongcheng Pharmaceutical Company Information
6.2.2 Yantai Dongcheng Pharmaceutical Description and Business Overview
6.2.3 Yantai Dongcheng Pharmaceutical Heparin Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Yantai Dongcheng Pharmaceutical Heparin Product Portfolio
6.2.5 Yantai Dongcheng Pharmaceutical Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Company Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Heparin Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Pfizer Heparin Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Bioibérica
6.4.1 Bioibérica Company Information
6.4.2 Bioibérica Description and Business Overview
6.4.3 Bioibérica Heparin Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Bioibérica Heparin Product Portfolio
6.4.5 Bioibérica Recent Developments/Updates
6.5 Changzhou Qianhong Biopharma
6.5.1 Changzhou Qianhong Biopharma Company Information
6.5.2 Changzhou Qianhong Biopharma Description and Business Overview
6.5.3 Changzhou Qianhong Biopharma Heparin Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Changzhou Qianhong Biopharma Heparin Product Portfolio
6.5.5 Changzhou Qianhong Biopharma Recent Developments/Updates
6.6 Nanjing King-friend Biochemical Pharmaceutical
6.6.1 Nanjing King-friend Biochemical Pharmaceutical Company Information
6.6.2 Nanjing King-friend Biochemical Pharmaceutical Description and Business Overview
6.6.3 Nanjing King-friend Biochemical Pharmaceutical Heparin Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Nanjing King-friend Biochemical Pharmaceutical Heparin Product Portfolio
6.6.5 Nanjing King-friend Biochemical Pharmaceutical Recent Developments/Updates
6.7 Hebei Changshan Biochemical Pharmaceutical
6.7.1 Hebei Changshan Biochemical Pharmaceutical Company Information
6.7.2 Hebei Changshan Biochemical Pharmaceutical Description and Business Overview
6.7.3 Hebei Changshan Biochemical Pharmaceutical Heparin Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Hebei Changshan Biochemical Pharmaceutical Heparin Product Portfolio
6.7.5 Hebei Changshan Biochemical Pharmaceutical Recent Developments/Updates
6.8 Qingdao Jiulong Biopharmaceutical
6.8.1 Qingdao Jiulong Biopharmaceutical Company Information
6.8.2 Qingdao Jiulong Biopharmaceutical Description and Business Overview
6.8.3 Qingdao Jiulong Biopharmaceutical Heparin Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Qingdao Jiulong Biopharmaceutical Heparin Product Portfolio
6.8.5 Qingdao Jiulong Biopharmaceutical Recent Developments/Updates
6.9 Opocrin
6.9.1 Opocrin Company Information
6.9.2 Opocrin Description and Business Overview
6.9.3 Opocrin Heparin Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Opocrin Heparin Product Portfolio
6.9.5 Opocrin Recent Developments/Updates
6.10 Dongying Tiandong Pharmaceutical
6.10.1 Dongying Tiandong Pharmaceutical Company Information
6.10.2 Dongying Tiandong Pharmaceutical Description and Business Overview
6.10.3 Dongying Tiandong Pharmaceutical Heparin Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Dongying Tiandong Pharmaceutical Heparin Product Portfolio
6.10.5 Dongying Tiandong Pharmaceutical Recent Developments/Updates
6.11 Aspen Oss
6.11.1 Aspen Oss Company Information
6.11.2 Aspen Oss Description and Business Overview
6.11.3 Aspen Oss Heparin Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Aspen Oss Heparin Product Portfolio
6.11.5 Aspen Oss Recent Developments/Updates
6.12 Yino Pharma
6.12.1 Yino Pharma Company Information
6.12.2 Yino Pharma Description and Business Overview
6.12.3 Yino Pharma Heparin Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Yino Pharma Heparin Product Portfolio
6.12.5 Yino Pharma Recent Developments/Updates
6.13 Nanjing Xinbai Pharmaceutical
6.13.1 Nanjing Xinbai Pharmaceutical Company Information
6.13.2 Nanjing Xinbai Pharmaceutical Description and Business Overview
6.13.3 Nanjing Xinbai Pharmaceutical Heparin Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Nanjing Xinbai Pharmaceutical Heparin Product Portfolio
6.13.5 Nanjing Xinbai Pharmaceutical Recent Developments/Updates
6.14 Hubei Enoray Biopharmaceutical
6.14.1 Hubei Enoray Biopharmaceutical Company Information
6.14.2 Hubei Enoray Biopharmaceutical Description and Business Overview
6.14.3 Hubei Enoray Biopharmaceutical Heparin Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Hubei Enoray Biopharmaceutical Heparin Product Portfolio
6.14.5 Hubei Enoray Biopharmaceutical Recent Developments/Updates
6.15 Cisen Pharmaceutical
6.15.1 Cisen Pharmaceutical Company Information
6.15.2 Cisen Pharmaceutical Description and Business Overview
6.15.3 Cisen Pharmaceutical Heparin Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Cisen Pharmaceutical Heparin Product Portfolio
6.15.5 Cisen Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Heparin Industry Chain Analysis
7.2 Heparin Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Heparin Production Mode & Process Analysis
7.4 Heparin Sales and Marketing
7.4.1 Heparin Sales Channels
7.4.2 Heparin Distributors
7.5 Heparin Customer Analysis
8 Heparin Market Dynamics
8.1 Heparin Industry Trends
8.2 Heparin Market Drivers
8.3 Heparin Market Challenges
8.4 Heparin Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Heparin Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Heparin Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Heparin Market Competitive Situation by Manufacturers in 2024
Table 4. Global Heparin Sales (billion units) of Key Manufacturers (2020-2025)
Table 5. Global Heparin Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Heparin Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Heparin Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Heparin Average Price (US$/billion units) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Heparin, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Heparin, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Heparin, Product Type & Application
Table 12. Global Key Manufacturers of Heparin, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Heparin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Heparin as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Heparin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Heparin Sales by Region (2020-2025) & (billion units)
Table 18. Global Heparin Sales Market Share by Region (2020-2025)
Table 19. Global Heparin Sales by Region (2026-2031) & (billion units)
Table 20. Global Heparin Sales Market Share by Region (2026-2031)
Table 21. Global Heparin Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Heparin Revenue Market Share by Region (2020-2025)
Table 23. Global Heparin Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Heparin Revenue Market Share by Region (2026-2031)
Table 25. North America Heparin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Heparin Sales by Country (2020-2025) & (billion units)
Table 27. North America Heparin Sales by Country (2026-2031) & (billion units)
Table 28. North America Heparin Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Heparin Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Heparin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Heparin Sales by Country (2020-2025) & (billion units)
Table 32. Europe Heparin Sales by Country (2026-2031) & (billion units)
Table 33. Europe Heparin Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Heparin Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Heparin Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Heparin Sales by Region (2020-2025) & (billion units)
Table 37. Asia Pacific Heparin Sales by Region (2026-2031) & (billion units)
Table 38. Asia Pacific Heparin Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Heparin Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Heparin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Heparin Sales by Country (2020-2025) & (billion units)
Table 42. Latin America Heparin Sales by Country (2026-2031) & (billion units)
Table 43. Latin America Heparin Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Heparin Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Heparin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Heparin Sales by Country (2020-2025) & (billion units)
Table 47. Middle East and Africa Heparin Sales by Country (2026-2031) & (billion units)
Table 48. Middle East and Africa Heparin Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Heparin Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Heparin Sales (billion units) by Type (2020-2025)
Table 51. Global Heparin Sales (billion units) by Type (2026-2031)
Table 52. Global Heparin Sales Market Share by Type (2020-2025)
Table 53. Global Heparin Sales Market Share by Type (2026-2031)
Table 54. Global Heparin Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Heparin Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Heparin Revenue Market Share by Type (2020-2025)
Table 57. Global Heparin Revenue Market Share by Type (2026-2031)
Table 58. Global Heparin Price (US$/billion units) by Type (2020-2025)
Table 59. Global Heparin Price (US$/billion units) by Type (2026-2031)
Table 60. Global Heparin Sales (billion units) by Application (2020-2025)
Table 61. Global Heparin Sales (billion units) by Application (2026-2031)
Table 62. Global Heparin Sales Market Share by Application (2020-2025)
Table 63. Global Heparin Sales Market Share by Application (2026-2031)
Table 64. Global Heparin Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Heparin Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Heparin Revenue Market Share by Application (2020-2025)
Table 67. Global Heparin Revenue Market Share by Application (2026-2031)
Table 68. Global Heparin Price (US$/billion units) by Application (2020-2025)
Table 69. Global Heparin Price (US$/billion units) by Application (2026-2031)
Table 70. Shenzhen Hepalink Pharmaceutical Company Information
Table 71. Shenzhen Hepalink Pharmaceutical Description and Business Overview
Table 72. Shenzhen Hepalink Pharmaceutical Heparin Sales (billion units), Revenue (US$ Million), Price (US$/billion units) and Gross Margin (2020-2025)
Table 73. Shenzhen Hepalink Pharmaceutical Heparin Product
Table 74. Shenzhen Hepalink Pharmaceutical Recent Developments/Updates
Table 75. Yantai Dongcheng Pharmaceutical Company Information
Table 76. Yantai Dongcheng Pharmaceutical Description and Business Overview
Table 77. Yantai Dongcheng Pharmaceutical Heparin Sales (billion units), Revenue (US$ Million), Price (US$/billion units) and Gross Margin (2020-2025)
Table 78. Yantai Dongcheng Pharmaceutical Heparin Product
Table 79. Yantai Dongcheng Pharmaceutical Recent Developments/Updates
Table 80. Pfizer Company Information
Table 81. Pfizer Description and Business Overview
Table 82. Pfizer Heparin Sales (billion units), Revenue (US$ Million), Price (US$/billion units) and Gross Margin (2020-2025)
Table 83. Pfizer Heparin Product
Table 84. Pfizer Recent Developments/Updates
Table 85. Bioibérica Company Information
Table 86. Bioibérica Description and Business Overview
Table 87. Bioibérica Heparin Sales (billion units), Revenue (US$ Million), Price (US$/billion units) and Gross Margin (2020-2025)
Table 88. Bioibérica Heparin Product
Table 89. Bioibérica Recent Developments/Updates
Table 90. Changzhou Qianhong Biopharma Company Information
Table 91. Changzhou Qianhong Biopharma Description and Business Overview
Table 92. Changzhou Qianhong Biopharma Heparin Sales (billion units), Revenue (US$ Million), Price (US$/billion units) and Gross Margin (2020-2025)
Table 93. Changzhou Qianhong Biopharma Heparin Product
Table 94. Changzhou Qianhong Biopharma Recent Developments/Updates
Table 95. Nanjing King-friend Biochemical Pharmaceutical Company Information
Table 96. Nanjing King-friend Biochemical Pharmaceutical Description and Business Overview
Table 97. Nanjing King-friend Biochemical Pharmaceutical Heparin Sales (billion units), Revenue (US$ Million), Price (US$/billion units) and Gross Margin (2020-2025)
Table 98. Nanjing King-friend Biochemical Pharmaceutical Heparin Product
Table 99. Nanjing King-friend Biochemical Pharmaceutical Recent Developments/Updates
Table 100. Hebei Changshan Biochemical Pharmaceutical Company Information
Table 101. Hebei Changshan Biochemical Pharmaceutical Description and Business Overview
Table 102. Hebei Changshan Biochemical Pharmaceutical Heparin Sales (billion units), Revenue (US$ Million), Price (US$/billion units) and Gross Margin (2020-2025)
Table 103. Hebei Changshan Biochemical Pharmaceutical Heparin Product
Table 104. Hebei Changshan Biochemical Pharmaceutical Recent Developments/Updates
Table 105. Qingdao Jiulong Biopharmaceutical Company Information
Table 106. Qingdao Jiulong Biopharmaceutical Description and Business Overview
Table 107. Qingdao Jiulong Biopharmaceutical Heparin Sales (billion units), Revenue (US$ Million), Price (US$/billion units) and Gross Margin (2020-2025)
Table 108. Qingdao Jiulong Biopharmaceutical Heparin Product
Table 109. Qingdao Jiulong Biopharmaceutical Recent Developments/Updates
Table 110. Opocrin Company Information
Table 111. Opocrin Description and Business Overview
Table 112. Opocrin Heparin Sales (billion units), Revenue (US$ Million), Price (US$/billion units) and Gross Margin (2020-2025)
Table 113. Opocrin Heparin Product
Table 114. Opocrin Recent Developments/Updates
Table 115. Dongying Tiandong Pharmaceutical Company Information
Table 116. Dongying Tiandong Pharmaceutical Description and Business Overview
Table 117. Dongying Tiandong Pharmaceutical Heparin Sales (billion units), Revenue (US$ Million), Price (US$/billion units) and Gross Margin (2020-2025)
Table 118. Dongying Tiandong Pharmaceutical Heparin Product
Table 119. Dongying Tiandong Pharmaceutical Recent Developments/Updates
Table 120. Aspen Oss Company Information
Table 121. Aspen Oss Description and Business Overview
Table 122. Aspen Oss Heparin Sales (billion units), Revenue (US$ Million), Price (US$/billion units) and Gross Margin (2020-2025)
Table 123. Aspen Oss Heparin Product
Table 124. Aspen Oss Recent Developments/Updates
Table 125. Yino Pharma Company Information
Table 126. Yino Pharma Description and Business Overview
Table 127. Yino Pharma Heparin Sales (billion units), Revenue (US$ Million), Price (US$/billion units) and Gross Margin (2020-2025)
Table 128. Yino Pharma Heparin Product
Table 129. Yino Pharma Recent Developments/Updates
Table 130. Nanjing Xinbai Pharmaceutical Company Information
Table 131. Nanjing Xinbai Pharmaceutical Description and Business Overview
Table 132. Nanjing Xinbai Pharmaceutical Heparin Sales (billion units), Revenue (US$ Million), Price (US$/billion units) and Gross Margin (2020-2025)
Table 133. Nanjing Xinbai Pharmaceutical Heparin Product
Table 134. Nanjing Xinbai Pharmaceutical Recent Developments/Updates
Table 135. Hubei Enoray Biopharmaceutical Company Information
Table 136. Hubei Enoray Biopharmaceutical Description and Business Overview
Table 137. Hubei Enoray Biopharmaceutical Heparin Sales (billion units), Revenue (US$ Million), Price (US$/billion units) and Gross Margin (2020-2025)
Table 138. Hubei Enoray Biopharmaceutical Heparin Product
Table 139. Hubei Enoray Biopharmaceutical Recent Developments/Updates
Table 140. Cisen Pharmaceutical Company Information
Table 141. Cisen Pharmaceutical Description and Business Overview
Table 142. Cisen Pharmaceutical Heparin Sales (billion units), Revenue (US$ Million), Price (US$/billion units) and Gross Margin (2020-2025)
Table 143. Cisen Pharmaceutical Heparin Product
Table 144. Cisen Pharmaceutical Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Heparin Distributors List
Table 148. Heparin Customers List
Table 149. Heparin Market Trends
Table 150. Heparin Market Drivers
Table 151. Heparin Market Challenges
Table 152. Heparin Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Heparin
Figure 2. Global Heparin Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Heparin Market Share by Type: 2024 & 2031
Figure 4. Heparin Sodium Product Picture
Figure 5. Heparin Calcium Product Picture
Figure 6. Global Heparin Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Heparin Market Share by Application: 2024 & 2031
Figure 8. UFH
Figure 9. LMWH
Figure 10. Global Heparin Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Heparin Market Size (2020-2031) & (US$ Million)
Figure 12. Global Heparin Sales (2020-2031) & (billion units)
Figure 13. Global Heparin Average Price (US$/billion units) & (2020-2031)
Figure 14. Heparin Report Years Considered
Figure 15. Heparin Sales Share by Manufacturers in 2024
Figure 16. Global Heparin Revenue Share by Manufacturers in 2024
Figure 17. Global 5 and 10 Largest Heparin Players: Market Share by Revenue in Heparin in 2024
Figure 18. Heparin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. Global Heparin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America Heparin Sales Market Share by Country (2020-2031)
Figure 21. North America Heparin Revenue Market Share by Country (2020-2031)
Figure 22. United States Heparin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada Heparin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Europe Heparin Sales Market Share by Country (2020-2031)
Figure 25. Europe Heparin Revenue Market Share by Country (2020-2031)
Figure 26. Germany Heparin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. France Heparin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. U.K. Heparin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Italy Heparin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Russia Heparin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Heparin Sales Market Share by Region (2020-2031)
Figure 32. Asia Pacific Heparin Revenue Market Share by Region (2020-2031)
Figure 33. China Heparin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Japan Heparin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. South Korea Heparin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. India Heparin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Australia Heparin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Taiwan Heparin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Indonesia Heparin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Thailand Heparin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Malaysia Heparin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Philippines Heparin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Heparin Sales Market Share by Country (2020-2031)
Figure 44. Latin America Heparin Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Heparin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Heparin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Heparin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Heparin Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Heparin Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Heparin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Heparin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. U.A.E Heparin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Heparin by Type (2020-2031)
Figure 54. Global Revenue Market Share of Heparin by Type (2020-2031)
Figure 55. Global Heparin Price (US$/billion units) by Type (2020-2031)
Figure 56. Global Sales Market Share of Heparin by Application (2020-2031)
Figure 57. Global Revenue Market Share of Heparin by Application (2020-2031)
Figure 58. Global Heparin Price (US$/billion units) by Application (2020-2031)
Figure 59. Heparin Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Heparin in 2031?
The global market size of Heparin in 2031 was 2301 Million USD.
What is the annual compound growth rate of the global Heparin market size from 2025 to 2031?
Which region is expected to have the highest market share?
What was the global market size of Heparin in 2025?
Which companies rank high in the global Heparin market?
Related Reports
Global Heparin Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Heparin market size was US$ 1469 million in 2025 and is forecast to reach a readjusted size of US$ 2462 million by 2032 with a CAGR of 7.8% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 92
USD 4250.00
(Single User License)
Global Heparin Market Research Report 2026
The global Heparin market was valued at US$ 1469 million in 2025 and is anticipated to reach US$ 2462 million by 2032, at a CAGR of 7.8% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 121
USD 2900.00
(Single User License)
Heparin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Heparin was estimated to be worth US$ 1469 million in 2025 and is projected to reach US$ 2462 million, growing at a CAGR of 7.8% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 130
USD 3950.00
(Single User License)
Global Heparin Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Heparin market is projected to grow from US$ 1225 million in 2024 to US$ 2301 million by 2031, at a CAGR of 7.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 166
USD 4900.00
(Single User License)
Heparin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Heparin was estimated to be worth US$ 1225 million in 2024 and is forecast to a readjusted size of US$ 2301 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published Date: 2025-08-27
Pages: 113
USD 3950.00
(Single User License)
Global Heparin Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Heparin market size was US$ 1225 million in 2024 and is forecast to a readjusted size of US$ 2301 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published Date: 2025-08-27
Pages: 93
USD 4250.00
(Single User License)
Global Heparin Market Insights, Forecast to 2031
The global Heparin market is projected to grow from US$ 1966 million in 2025 to US$ 3083 million by 2031, at a Compound Annual Growth Rate (CAGR) of 7.8% during the forecast period.
Published Date: 2025-05-07
Pages: 150
USD 4900.00
(Single User License)
Global Heparin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Heparin was estimated to be worth US$ 2134 million and is forecast to reach approximately US$ 3489 million by 2031 with a CAGR of 7.4% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 147
USD 5900.00
(Single User License)
Heparin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Heparin was estimated to be worth US$ 2134 million in 2024 and is forecast to a readjusted size of US$ 3489 million by 2031 with a CAGR of 7.4% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 130
USD 3950.00
(Single User License)
Global Heparin Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Heparin is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium.
Published Date: 2024-04-17
Pages: 177
USD 5600.00
(Single User License)
Global Heparin Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Heparin market size was US$ 1469 million in 2025 and is forecast to reach a readjusted size of US$ 2462 million by 2032 with a CAGR of 7.8% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 92
USD 4250.00 (Single User License)Global Heparin Market Research Report 2026
The global Heparin market was valued at US$ 1469 million in 2025 and is anticipated to reach US$ 2462 million by 2032, at a CAGR of 7.8% from 2026 to 2032.
Published: 2026-01-04
Pages: 121
USD 2900.00 (Single User License)Heparin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Heparin was estimated to be worth US$ 1469 million in 2025 and is projected to reach US$ 2462 million, growing at a CAGR of 7.8% from 2026 to 2032.
Published: 2026-01-04
Pages: 130
USD 3950.00 (Single User License)Global Heparin Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Heparin market is projected to grow from US$ 1225 million in 2024 to US$ 2301 million by 2031, at a CAGR of 7.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 166
USD 4900.00 (Single User License)Heparin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Heparin was estimated to be worth US$ 1225 million in 2024 and is forecast to a readjusted size of US$ 2301 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published: 2025-08-27
Pages: 113
USD 3950.00 (Single User License)Global Heparin Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Heparin market size was US$ 1225 million in 2024 and is forecast to a readjusted size of US$ 2301 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published: 2025-08-27
Pages: 93
USD 4250.00 (Single User License)Global Heparin Market Insights, Forecast to 2031
The global Heparin market is projected to grow from US$ 1966 million in 2025 to US$ 3083 million by 2031, at a Compound Annual Growth Rate (CAGR) of 7.8% during the forecast period.
Published: 2025-05-07
Pages: 150
USD 4900.00 (Single User License)Global Heparin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Heparin was estimated to be worth US$ 2134 million and is forecast to reach approximately US$ 3489 million by 2031 with a CAGR of 7.4% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 147
USD 5900.00 (Single User License)Heparin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Heparin was estimated to be worth US$ 2134 million in 2024 and is forecast to a readjusted size of US$ 3489 million by 2031 with a CAGR of 7.4% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 130
USD 3950.00 (Single User License)Global Heparin Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Heparin is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium.
Published: 2024-04-17
Pages: 177
USD 5600.00 (Single User License)
CHOOSE LICENSE TYPE
USD 2900.00
USD 4350.00
USD 5800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
REPORT SCOPE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now